BDBM621899 (S)-N-((R or S)-(4- chloro-3- cyanophenyl)(4- (trifluoromethoxy) phenyl)methyl)-2- oxoimidazolidine-4- carboxamide::US20230312528, Example 57A

SMILES FC(F)(F)Oc1ccc(cc1)[C@H](NC(=O)[C@@H]1CNC(=O)N1)c1ccc(Cl)c(c1)C#N

InChI Key InChIKey=QEPBHTRFWCUOCU-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 621899   

TargetSodium channel protein type 8 subunit alpha(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM621899(US20230312528, Example 57A | (S)-N-((R or S)-(4- c...)
Affinity DataIC50: 3.5nMAssay Description:Compounds were tested on human NaV1.8 and NaV1.5 channels stably expressed in human embryo kidney (HEK) 293 cells. Sodium current measurements on Qub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent